Ocular Therapeutix™ Announces Topline Results of Phase 3 Clinical Trial of DEXTENZA® for the Treatment of Ocular Itching Associated with Allergic Conjunctivitis

Tuesday, April 28, 2020 8:30 AM EDT

Webcast Presentation

Title
Ocular Therapeutix™ Announces Topline Results of Phase 3 Clinical Trial of DEXTENZA® for the Treatment of Ocular Itching Associated with Allergic Conjunctivitis
Date / Time
Tuesday, April 28, 2020 8:30 AM EDT